These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28754233)

  • 1. Development and validation of an alternative version of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS).
    Fernández-Bobadilla R; Martínez-Horta S; Marín-Lahoz J; Horta-Barba A; Pagonabarraga J; Kulisevsky J
    Parkinsonism Relat Disord; 2017 Oct; 43():73-77. PubMed ID: 28754233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
    Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
    Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Italian version of the alternative form of Parkinson's Disease-Cognitive Rating Scale (PD-CRS/AF): normative values from 260 Italian healthy subjects.
    D'Iorio A; Maggi G; Baiano C; Santangelo G
    Neurol Sci; 2022 Jun; 43(6):3613-3620. PubMed ID: 35083571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.
    Kulisevsky J; Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Campolongo A; García-Sánchez C; Pascual-Sedano B; Ribosa-Nogué R; Villa-Bonomo C
    Parkinsonism Relat Disord; 2013 Sep; 19(9):812-7. PubMed ID: 23773412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.
    Mahmoudi Asl A; Mehdizadeh M; Kulisevsky J; Sabet A; Taghavi Azar Sharabiani P; Mehdizadeh H; Ashayeri H; Taghizadeh G
    Disabil Rehabil; 2022 May; 44(10):2091-2098. PubMed ID: 32924645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.
    Santangelo G; Lagravinese G; Battini V; Chiorri C; Siciliano M; Abbruzzese G; Vitale C; Barone P
    Neurol Sci; 2017 May; 38(5):845-853. PubMed ID: 28224328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
    Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
    Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS).
    Santangelo G; Barone P; Abbruzzese G; Ferini-Strambi L; Antonini A;
    Neurol Sci; 2014 Apr; 35(4):537-44. PubMed ID: 24221858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale.
    Garon M; Weis L; Siquier A; Fiorenzato E; Pistonesi F; Cianci V; Canesi M; Pesce F; Reali E; Pozzi B; Isaias IU; Siri C; Santangelo G; Cuoco S; Barone P; Kulisevsky J; Antonini A; Biundo R
    J Neural Transm (Vienna); 2024 Apr; 131(4):305-314. PubMed ID: 38280057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Revised Chinese Version of PD-CRS in Parkinson's Disease Patients.
    Tan Y; Liu W; Du J; Hou M; Yu C; Liu Y; Cui S; Yan L; Lu Y; Lv H; Han L; Wang X; Zha S; Luo X; Tang H; Chen S
    Parkinsons Dis; 2020; 2020():5289136. PubMed ID: 32148754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment.
    Pirogovsky E; Schiehser DM; Litvan I; Obtera KM; Burke MM; Lessig SL; Song DD; Liu L; Filoteo JV
    Parkinsonism Relat Disord; 2014 Jun; 20(6):627-31. PubMed ID: 24709086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
    Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
    J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's Disease--Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment.
    Ruzafa-Valiente E; Fernández-Bobadilla R; García-Sánchez C; Pagonabarraga J; Martínez-Horta S; Kulisevsky J
    J Neurol Sci; 2016 Feb; 361():66-71. PubMed ID: 26810519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's Disease-Cognitive Rating Scale (PD-CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil.
    Brandão PRP; Pereira DA; Grippe TC; Bispo DDC; Maluf FB; Yunes MP; Nunes Filho G; Alves CHL; Pagonabarraga J; Kulisevsky J; da Costa AML; Serafim CFDV; Ferreira ACDB; Bastos AMM; Belchior ACF; de Almeida BLC; de Almeida E Castro BM; Matos MS; de Matos RC; Rios GA; Carneiro LO; da Mota BCC; Castro LEDR; Rocha VLS; Tavares MCH; Cardoso F
    Mov Disord Clin Pract; 2023 Mar; 10(3):452-465. PubMed ID: 36949793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.
    Holden SK; Medina LD; Hoyt B; Sillau SH; Berman BD; Goldman JG; Weintraub D; Kluger BM
    Mov Disord; 2018 Nov; 33(11):1760-1768. PubMed ID: 30306618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.